MannKind Corporation (MNKD)
Free
No email, no account, no signup.
Pulling latest news for MannKind Corporation…
Bull
Bear
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99.
Get the deep 4-model report – $4.99
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
NASDAQ
Type
Biotech
Sector
Biopharmaceuticals and drug delivery
Market Cap
$1.1B
We're already tracking MannKind Corporation — here are the latest events we've registered
Recent News
- On May 6, 2026, MannKind reported Q1 2026 total revenues of $90.2 million, representing a 15% increase compared to the previous year, primarily fueled by Furoscix sales and Tyvaso DPI royalties. During the quarter, the company settled its remaining $36.3 million in senior convertible notes to strengthen its balance sheet. Management highlighted upcoming FDA PDUFA dates for Afrezza’s pediatric indication on May 29, 2026, and the Furoscix ReadyFlow autoinjector on July 26, 2026.
Want to know how this news affects MannKind Corporation? Order the analysis.
Order analysis – $4.99
What you get
A complete express analysis — not just a signal. Delivered as a webpage in your account.
- Signal: BUY / HOLD / SELL — with clear reasoning
- Sentiment score 1–10 based on news, reports, and market data
- Risk score 1–10 (dilution, jurisdiction, execution)
- Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
- Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
- Upcoming catalysts with dates
- Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of MannKind Corporation will be delivered in the same format.
Not satisfied? Get your money back within 7 days — no questions asked.
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.